Skip to main content
Live Signal Feed

Jubilant Biosys

PromotionDetected 13h ago · North America

Jubilant Biosys has promoted Jay Sheth to the expanded role of Head of CDMO, North America, in addition to his current position as AVP, Business Development & Global Head of Venture Capital Relations.

Why it matters for sellers

Rising champion = warm relationship to build on

Read the original coveragevia indianpharmapost.com

Signal details

Reported
September 5, 2026
Source
indianpharmapost.com

From the coverage · indianpharmapost.com

By: IPP Bureau Last updated : September 06, 2026 11:04 am Sheth brings extensive experience across contract development and manufacturing, drug discovery services, business development and strategic partnerships Jubilant Biosys Limited has expanded Jay Sheth’s leadership mandate with his appointment as Head of CDMO, North America, alongside his existing role as AVP, Business Development & Global Head of Venture Capital Relations. In his expanded role, Sheth will lead the company’s CDMO business development activities across North America, focusing on strengthening client relationships, building strategic partnerships and expanding opportunities across the pharmaceutical and biotechnology ecosystem.

He will continue to oversee Jubilant Biosys’ global venture capital relationships and contribute to the company’s broader business development and growth initiatives. Sheth brings extensive experience across contract development and manufacturing, drug discovery services, business development and strategic partnerships. His previous leadership and commercial roles include positions at Jubilant Biosys, Eurofins Advinus, Syngene International, Shasun, TRG and Zydus Group.

Continue reading at indianpharmapost.com

Get signals like this for every account you sell to

Our engine detects, verifies, and deduplicates thousands of buying signals every day across 50M+ companies — delivered via API, GCS push, or flat file.